DySIS Medical wins prestigious Innovation Award

DySIS Medical Ltd, a  medical devices company specialising  in female health, was revealed as the winner of the Innovation Award for 2013 at the annual awards ceremony.

 DySIS colposcopy uses spectral imaging to help clinicians highlight any areas of concern by mapping out the condition of a woman’s cervix.  In clinical trials, it has been shown to significantly boost sensitivity in detecting cervical cancer in its earliest stages.  Armed with this additional information, clinicians are able to take immediate steps to treat patients and prevent disease progression.   

CEO, Alastair Atkinson said "I'm delighted to receive this award on behalf of the company. It represents further recognition that our product, DySIS, is setting new standards in women's healthcare. Cervical Cancer is an entirely preventable disease if it is detected early enough. The detection rate of DySIS is greater than 90%, in comparison to around 50% for traditional methods, and is therefore delivering substantial benefits in both patient outcomes and healthcare costs."